A leading cannabis real estate investment trust (REIT) firm has signed a long-term deal with Green Thumb Industries (GTI) (CSE:GTII,OTCQX:GTBIF).

On Monday (February 3), Innovative Industrial Properties (IIP) (NYSE:IIPR) confirmed that its new partnership with the Illinois-based multi-state operator (MSO) will begin with a sale-leaseback transaction for a processing facility in Toledo, Ohio.


This isn’t the first agreement completed between the two firms, as last year the duo came together for a cultivation and processing facility sale-leaseback agreement in Danville, Pennsylvania.

Ben Kovler, GTI’s founder and CEO, said in a statement that the funds for the deal in Ohio will be used for expansion purposes.

“IIP provides a flexible real estate capital solution that effectively addresses our expansion needs at the processing facility in Toledo,” the GTI executive said.

The total agreed sum for the facility is US$7.2 million, given that GTI completes a list of undisclosed improvements to the operation. If the facility work is not completed, IIP will only pay US$2.9 million, according to the joint announcement from the US firms.

“GTI continues to distinguish itself with its cannabis product offerings and dedication to patient experience and right to well-being, providing safe, high quality cannabis products in a compassionate environment,” said Paul Smithers, president and CEO of IIP.

The market offered differing takes for each company on the announcement. Shares of IIP soared at open, and as of 1:30 p.m. EST were trading at US$92.74, representing an increase of 3.7 percent.

On the other hand, GTI shares dragged in Monday’s trading session with a 3.4 percent drop in value, resulting in a price per share of US$12.22.

IIP has quickly embedded itself as a capital solution for cannabis companies facing the harsher realities of the capital markets, thanks to the REIT strategy.

The REIT company has seen this interest reflected in its share price so far this year, experiencing a jump in value of over 20 percent. While most of the cannabis universe has struggled recently, IIP has continued to grow and offer investors access to a cannabis play while remaining compliant with regulations for the New York Stock Exchange.

stock chart for IIP

In a previous interview with the Investing News Network (INN), Smithers said investors feel more comfortable with the company as it adheres strictly to real estate operations. With every deal completed, IIP does not obtain a stake in the cannabis company participant.

“We’re strictly a real estate company and I think there’s a certain group of investors that like that. It’s a little more stability than a company that is perhaps growing,” said Smithers.

MSOs in the US have embraced the REIT model, with fellow MSO Cresco Labs (CSE:CL,OTCQX:CRLBF) completing separate agreements with both IIP and GreenAcreage Real Estate.

“It becomes a higher operating cost that that company will incur for the term of the lease and some of these are 15 years, and they’re not very cheap,” Mike Regan, an analyst with Marijuana Business Daily’s Investor Intelligence, previously told INN. “But that’s still cheaper than going out of business.”

Shares of the REIT company have been added to the recently debuted Medical Cannabis & Wellness UCITS ETF (XETRA:CBDX). The fund trades in Europe and offers investors established cannabis plays with no connection to the recreational space in North America.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less